Venoms from eight snakes have been screened for inhibitory activity against papain, strong activity being found in that of the African puff adQr,,Bitis arietans. Theinhibitor from B. arietans venom has been purified by affinity chromatography on carboxyyot a Sepharose and ion-exchange chromatography. The inhibitor had an apparent Mr of 13000 in yDaeo1yacrylamide gel electrophoresis, and pI value of 6.5 (major component) or 6.3 (minor copow). Values of K, for the inhibition of papain, cathepsin B and dipeptidyl peptidase I were 0.10, 2.7 an&0.23 nm, respectively; chicken calpain was not inhibited.
Methods
Protein inhibitors of seine proteinases are extremely numerous, and have been studied in great detail, but much less is known about inhibitors of cysteine, aspartic and metalloproteinases. All of the tight-binding protein inhibitors of the papain-like cysteine proteinases that have been examined in detail have been from avian or mammalian species. These have all proved to be members of the cystatin superfamily, and each falls into one of the three distinct but homologous protein types or families (Barrett et al., 1986a,b) .
Proteinase inhibitors of reptiles have received far less attention than those of mammals, but are of considerable evolutionary interest. An inhibitor of the cysteine proteinases, papain and cathepsins B and H, was isolated from the venom of Vipera ammodytes, but not further characterized (Kregar et al., 1981) . We have now examined other snake venoms for cysteine proteinase inhibitors, and, having found one, have isolated and characterized it.
EXPERIMENTAL

Materials
The venoms of Agkistrodon piscivorus piscivorus, Bitis arietans, Bitis nasicornus, Crotalus atrox, Naja nivea, Naja naja atra, Vipera ammodytes and Vipera russelli, as well as papain and bovine dipeptidyl peptidase I, were obtained from Sigma Chemical Co. The substrates ZPhe-Arg-NHMec, Gly-Phe-NHMec and Suc-Leu-TyrNHMec were obtained from Bachem Feinchemikalien AG, Bubendorf, Switzerland.
Human cathepsin B (Rich et al., 1986) and chicken gizzard calpain (Parkes et al., 1985) were available in the laboratory. Cm-papain-Sepharose and egg-white cystatin were prepared as described by Anastasi et al. (1983) .
Purification of inhibitor from venom of puff adder. B; arietans venom (1.0 g) was suspended in 100 ml of 0.05 M-sodium phosphate buffer, pH 6.5, containing 1 mM-EDTA, 1 mM-iodoacetic acid and 1 mM-phenylmethanesulphonyl fluoride, and insoluble material was removed by two passes through a Whatman glass microfibre filter (type GF/D). The resulting solution was applied to a Cm-papain-Sepharose column (14 cm x 5 cm, 275 ml bed volume) that had been equilibrated with 0.05 Msodium phosphate buffer, pH 6.5. The column was washed with the same buffer until the A280 approached zero, and bound protein was eluted with 0.05 Mpotassium phosphate/NaOH (pH-11.5). Fractions (4 ml) were collected into tubes containing 1 ml of 0.25 M-KH2PO4 to bring the pH to 7.0.
Fractions from the Cm-papain-Sepharose column that showed significant inhibitory activity for papain were combined, and the pool was centrifuged at 8000 g for 30 min. The supernatant solution was concentrated by ultrafiltration over an Amicon YM-5 membrane under pressure of N2, dialysed against 20 mM-Tris/HCl (pH 8.0), centrifuged at 8000 g for 30 min, and applied to an f.p.l.c. (Pharmacia system) Mono Q anion exchange column (10 cm x 1 cm) that had been equilibrated with the same buffer. A linear gradient from 20 mm to 220 mM-Tris/HCl (pH 8.0) was applied (2 ml/min) to elute the inhibitor. Again, the most active fractions were combined.
Electrophoresis and isoelectric focusing. SDS/polyacrylamide gel electrophoresis was as described (Bury, 1981) , with slab gels containing 12.5 % total acrylamides. Isoelectric focusing was with ampholines covering the range pH5.0-8.0 (Barrett, 1973 NHMec as substrate at pH 6.0, dipeptidyl peptidase I with Gly-Phe-NHMec at pH 6.5, and calpain with SucLeu-Tyr-NHMec at pH 7.5 (Green et al., 1984; Parkes et al., 1985) . In screening assays to detect inhibitory activity for papain in the snake venoms, papain (5 ng) was used at pH 6.0, with Z-Phe-Arg-NHMec as substrate (5 #M) in stopped assays as described by Barrett (1980) . Initially, 3.6 ,ug of each venom was used, and the assay with B. arietans venom was repeated with 0.36 ,ug.
Kinetic values for the inhibition of papain, cathepsin B and dipeptidyl peptidase I were determined as described by Nicklin & Barrett (1984) . The concentrations of solutions of the venom inhibitor were determined by A280 on the assumption that A1% = 8.5, as for chicken cystatin (Anastasi et al., 1983) .
RESULTS AND DISCUSSION
Screening of venoms for ability to inhibit papain
The initial screening of venoms for inhibition of papain gave the results shown in Table 1 . The venoms of eastern cottonmouth moccasin (A. piscivorus piscivorus), puff adder (B. arietans) and western diamondback rattlesnake (C. atrox) contained significant endogenous activity against the papain substrate, Z-Phe-ArgNHMec, in the absence of papain. When the papain activity in the presence of each venom was corrected for the activity of the venom alone, it was obvious that only puff adder venom showed strong inhibition of papain. A 10-fold dilution of the puff adder venom also inhibited papain completely. In a second experiment (not shown), venoms from two other viper species were examined in exactly the same way. Bitis nasicornus showed slightly weaker activity than B. arietans, and Vipera ammodytes much weaker (although significant) inhibitory activity.
The species tested represent three families of snakes, the Elapidae, Viperidae and Crotalidae, but only three of the four species from the Viperidae showed significant activity. The only previous report of a cysteine proteinase inhibitor from a snake venom was for-Vipera ammodytes (Kregar et al., 1981) . Purification of the cysteine proteinase inhibitor from puff adder venom The inhibitor was purified by an affinity chromatography procedure used previously for chicken cystatin (Anastasi et al., 1983 ) and f.p.l.c. anion exchange chromatography. Affinity chromatography of puff adder venom on Cm-papain-Sepharose gave a single protein peak comprising about 4 % of the starting material. Much inactive protein was precipitated following the neutralization of the fractions, as was reported previously for the purification of human liver cystatins (Green et al., 1984) .
All of the protein recovered in the supernatant solution after concentration, dialysis and centrifugation was loaded on to the f.p.l.c. Mono Q column. One large peak containing most of the inhibitory activity was resolved from several smaller peaks which also inhibited papain. The final column wash with 1.0 M-Tris/HCl, pH 8.0, eluted only inactive protein. Fractions comprising the major peak were combined, and this material (5.7 A280 units) was the purified inhibitor used in further work.
The purified inhibitor ran as a single component in SDS/polyacrylamide gel electrophoresis, with mobility similar to those of cytochrome c and chicken cystatin, indic'ating an Mr of about 13000. Further evidence of homogeneity was obtained by isoelectric focusing, which gave a major band with a pl of 6.5 estimated to comprise about 90 % of the preparation; the other 10 % migrated with a pI of 6.3.
Inhibitory activities
The inhibition constants for the interaction of puff adder inhibitor with papain, cathepsin B and dipeptidyl peptidase I are summarized and compared with those of various cystatins in Table 2 . Values of k,1 and k-, were found to be 8.5 x 10 m's-s-' and 2.3 x 10-4 S-1 for cathepsin B, and 5.9 x 106 M-1 s-1 and 1.4 x 10-s-1 for dipeptidyl peptidase I.
The venom inhibitor (92 nM) showed no inhibition of chicken calpain.
The inhibitory spectrum of the puff adder inhibitor against cysteine proteinases is similar to those of Type 1 and Type 2 cystatins; Type 3 cystatins (kininogens) inhibit calpain with K1 about 1 nm (Salvesen et al., 1986) , which the venom inhibitor did not.
The molecular size and inhibitory properties of the B. arietans venom cysteine proteinase inhibitor are consistent with its being a member of the cystatin superfamily (Barrett et al., 1986a,b) , and the results of amino acid sequence analysis (Ritonja et al., 1987) confirm this classification.
